From Cell Painting to AI Assisted CT Scans: Holistically Using Science & Medicine to Better Monitor, Prevent & Detect Interstitial Lung Disease in Solid Tumor Patients Treated with ADCs
- Evaluating distinctive trends in ADC clinical trials and real-world data to characterize areas for risk mitigation
- Establishing a non-clinical toolbox for comprehending pathophysiologic mechanism of action to support ADC asset design and screening
- Embracing innovative, non-traditional methods to elevate risk comprehension to better select patients or decrease incidence of ILD